PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Successful outcome prompts early end to sickle cell anemia clinical trial

Data show hydroxyurea therapy offers safe, effective disease management

2014-11-19
(Press-News.org) CINCINNATI - Conclusive data show that hydroxyurea therapy offers safe and effective disease management of sickle cell anemia (SCA) and reduces the risk of stroke, prompting early termination by the National Heart Lung and Blood Institute (NHLBI) of a key clinical trial studying the drug's efficacy.

NHLBI officials issued the announcement today, about one year before the study was originally scheduled to end. Going by the title TWiTCH (TCD With Transfusions Changing to Hydroxyurea), the Phase III randomized clinical trial at 25 medical centers in the U.S. and Canada compared standard therapy (monthly erythrocyte transfusions) with the alternative (daily hydroxyurea) for children with elevated transcranial Doppler (TCD) velocities and high risk of stroke.

"Early results indicate that TWiTCH is a success. Hydroxyurea works as well as blood transfusions to lower TCD velocities, which lowers the risk of the child having a stroke," said Russell E. Ware, MD, PhD, principal investigator of the study and director of Hematology at Cincinnati Children's Hospital Medical Center, which served as the study's Medical Coordinating Center.

"A group of outside experts has been reviewing the TWiTCH data every few months to ensure the safety of children in the clinical trial and to monitor the data," Ware explained. "This group met recently and after careful consideration of the interim data results, recommended that the study be stopped since hydroxyurea worked as well as transfusions to lower TCD velocities." The NHLBI and National Institutes of Health (NIH) agreed with the recommendation. "No child should ever suffer a stroke, which is why it was so important for the NHLBI to support the TWiTCH trial," said Gary Gibbons, MD, director of the NHLBI. "This critical research finding opens the door to more treatment options for clinicians trying to prevent strokes in children living with the sickle cell disease." The study enrolled its first patient in September 2011 and included children between ages 4 and 16 years with sickle cell anemia and abnormally elevated TCD velocities, which increases their risk of developing a stroke. The current standard therapy for children with elevated TCD velocities is monthly blood transfusions. A total of 121 children were randomized: half received the standard therapy of transfusions while the other half received the alternate treatment with daily hydroxyurea, which has not yet been approved for children with sickle cell anemia.

The clinical data-collection portion of the study was originally scheduled for 24 months, but collection is now being stopped early, after only half of the children have completed the treatment phase.

"We did not know if hydroxyurea would reduce the risk of stroke as well as transfusions, so TWiTCH was an important research study," said Barry R. Davis, MD, PhD, principal investigator for the Data Coordinating Center at the University of Texas Health Science Center at Houston (UTHealth) School of Public Health. "The study has now shown that hydroxyurea has a similar benefit as transfusions, so the study is closing early since the main research question has been answered."

An important reason for testing hydroxyurea is that the current standard therapy of monthly blood transfusions to reduce stroke risk can lead to problems such as antibody formation and iron overload, which are increasingly recognized as a source of morbidity in young patients with SCA.

Over the past decade, the laboratory and clinical efficacy of hydroxyurea has been demonstrated in children and adults with SCA. Originally developed as a drug to treat cancer and infections, hydroxyurea boosts fetal hemoglobin production in SCA, which prevents the red blood cells from acquiring the sickled shape that fuels the many complications. Hydroxyurea has been previously shown to have clinical efficacy for a variety of sickle-related complications, but TWiTCH is the first Phase III trial that demonstrates its benefits for children with cerebrovascular disease and increased stroke risk.

INFORMATION:

Serving as co-principal investigator for the study's neurological core was Robert J. Adams, MD, Medical University of South Carolina.

NHLBI advisory: http://www.nhlbi.nih.gov/news/press-releases/2014/nhlbi-media-availability-nih-ends-transcranial-doppler-tcd-with-transfusions-changing-to-hydroxyurea-twitch-clinical-trial-due-to-early-results.html For more information, please visit: Cincinnati Children's Hospital Medical Center: http://www.cincinnatichildrens.org/default/ University of Texas Health Science Center at Houston (UTHealth): http://www.uth.edu/ Medical University of South Carolina: http://academicdepartments.musc.edu/musc/ Media contact for Dr. Davis at UT Health: Hannah Rhodes, 713-500-3053, hannah.c.rasorrhodes@uth.tmc.edu .



ELSE PRESS RELEASES FROM THIS DATE:

Study: Teens who mature early at greater risk of depression

2014-11-19
CHAMPAIGN, Ill. -- Youth who enter puberty ahead of their peers are at heightened risk of depression, although the disease develops differently in girls than in boys, a new study suggests. Early maturation triggers an array of psychological, social-behavioral and interpersonal difficulties that predict elevated levels of depression in boys and girls several years later, according to research by led by psychology professor Karen D. Rudolph at the University of Illinois. Rudolph and her colleagues measured pubertal timing and tracked levels of depression among more than ...

'Green Revolution' changes breathing of the biosphere

Green Revolution changes breathing of the biosphere
2014-11-19
The intense farming practices of the "Green Revolution" are powerful enough to alter Earth's atmosphere at an ever-increasing rate, boosting the seasonal amplitude in atmospheric carbon dioxide to about 15 percent during the last five decades. That's the key finding of a new atmospheric model that estimates that on average, the amplitude of the seasonal oscillation of carbon dioxide in the atmosphere is increasing at the rate of 0.3 percent every year. A report on the results of the model, called VEGAS, is published today in the journal Nature. "What we are seeing ...

Boosts in productivity of corn and other crops modify Northern Hemisphere carbon dioxide cycle

2014-11-19
Each year in the Northern Hemisphere, levels of atmospheric carbon dioxide drop in the summer as plants "inhale," then climb again as they exhale after the growing season. During the last 50 years, the size of this seasonal swing has increased by as much as half, for reasons that aren't fully understood. Now a team of researchers has shown that agricultural production may generate up to a quarter of the increase in this seasonal carbon cycle, with corn playing a leading role. "This study shows the power of modeling and data mining in addressing potential sources ...

HHS and NIH take steps to enhance transparency of clinical trial results

2014-11-19
The U.S. Department of Health and Human Services today issued a Notice of Proposed Rulemaking (NPRM), which proposes regulations to implement reporting requirements for clinical trials that are subject to Title VIII of the Food and Drug Administration Amendments Act of 2007 (FDAAA). The proposed rule clarifies requirements to clinical researchers for registering clinical trials and submitting summary trial results information to ClinicalTrials.gov, a publicly accessible database operated by the National Library of Medicine, part of the National Institutes of Health. A ...

Syracuse geologists shed light on formation of Alaska Range

Syracuse geologists shed light on formation of Alaska Range
2014-11-19
Geologists in Syracuse University's College of Arts and Sciences have recently figured out what has caused the Alaska Range to form the way it has and why the range boasts such an enigmatic topographic signature. The narrow mountain range is home to some of the world's most dramatic topography, including 20,320-foot Mount McKinley, North America's highest mountain. Professor Paul Fitzgerald and a team of students and fellow scientists have been studying the Alaska Range along the Denali fault. They think they know why the fault is located where it is and what accounts ...

Power behind 'master' gene for cancer discovered

Power behind master gene for cancer discovered
2014-11-19
It's hard to believe, but there are similarities between bean sprouts and human cancer. In bean sprouts, a collection of amino acids known as a protein complex allows them to grow longer in the darkness than in the light. In humans, a similar protein complex called CSN and its subunit CSN6 is now believed to be a cancer-causing gene that impacts activity of another gene (Myc) tied to tumor growth. Somehow the same mechanisms that result in bigger bean sprouts, also cause cancer metastasis and tumor development. A study at The University of Texas MD Anderson Cancer ...

Camera trap images help wildlife managers ID problem tigers in India

Camera trap images help wildlife managers ID problem tigers in India
2014-11-19
Human-wildlife conflict resolution near protected areas critical for tiger survival Stripe-matching software and individual histories inform decisions on handling conflict-prone big cats NEW YORK (November 18, 2014)--Researchers with the Wildlife Conservation Society and other partners in India are using high-tech solutions to zero in on individual tigers in conflict and relocate them out of harm's way for the benefit of both tigers and people. In recent tiger-conflict cases involving both a human fatality and the predation of livestock, both occurring near two of ...

Living kidney donors more likely to be diagnosed with high BP or preeclampsia once pregnant

2014-11-19
Nearly 30,000 people become living kidney donors worldwide each year, and many are young women. Researchers at the Institute for Clinical Evaluative Sciences (ICES), Lawson Health Research Institute and Western University set out to determine if being a living donor has any effect on future pregnancies. The study, published in the New England Journal of Medicine, found living kidney donors were more likely to be diagnosed with gestational hypertension (high blood pressure) or preeclampsia than non-donors. Preeclampsia is a pregnancy complication characterized by high ...

South Asian boys are more likely to be overweight compared to peers, new study finds

2014-11-19
South Asian boys are three times as likely to be overweight compared to their peers, according to a new Women's College Hospital study. The report, which was recently published in the Journal of Racial and Ethnic Health Disparities, was one of the first to look at ethnic group differences in overweight children living in Canada. "Our findings are alarming. From a young age, South Asian boys appear to be on a path towards developing serious health conditions," said Ananya Banerjee, PhD, lead researcher of the study. Previous work has established that, in Canada, type ...

2008 Lacey Act Amendment successful in reducing US imports of illegally logged wood

2014-11-19
Recently published research by U.S. Forest Service economist Jeff Prestemon supports the contention that the 2008 Lacey Act Amendment reduced the supply of illegally harvested wood from South America and Asia available for export to the United States. Using monthly import data from 1989 to 2013, Prestemon, Project Leader of the Forest Service Southern Research Station Forest Economics and Policy unit, applied alternative statistical approaches to evaluate the effects of the 2008 amendment. The Journal of Forest Policy and Economics recently published the results online. ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Successful outcome prompts early end to sickle cell anemia clinical trial
Data show hydroxyurea therapy offers safe, effective disease management